This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Immuno-Biological Laboratories Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Yoichi Araki
Introduction
Yoichi Araki is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in relation to Alzheimer's disease. His innovative work has the potential to improve early detection methods for this debilitating condition.
Latest Patents
Araki holds a patent for a marker peptide for Alzheimer's disease. This invention provides a peptide that can be obtained by cleaving the N-terminal and C-terminal regions of Alcadein α, Alcadein β, or Alcadein γ. The peptide serves as a diagnostic marker, enabling the early detection of Alzheimer's disease without imposing a burden on the subjects being tested. This advancement could lead to more effective and less invasive diagnostic procedures.
Career Highlights
Throughout his career, Yoichi Araki has been associated with Immuno-Biological Laboratories Co., Ltd. His work at this company has allowed him to focus on developing innovative solutions in the field of biotechnology. His dedication to research and development has positioned him as a key figure in the fight against Alzheimer's disease.
Collaborations
Araki has collaborated with notable colleagues, including Toshiharu Suzuki and Naomi Miyagi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Yoichi Araki's contributions to the field of medical diagnostics, particularly through his patent for a marker peptide for Alzheimer's disease, highlight his innovative spirit and commitment to improving healthcare. His work continues to inspire advancements in the detection and understanding of this complex disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile